Dr. Michiel Strijbos is a Consultant Medical Oncologist at the AZ Klina hospital in Brasschaat, Antwerp, Belgium. He trained at Leuven University in Belgium and the Erasmus University in Rotterdam, Netherlands, where he graduated in 2004.
Between 2004 and 2009, he enrolled in a PhD project focusing on tumour vasculature at the Daniel den Hoed Cancer Center in Rotterdam, for which he was awarded a PhD.
Dr. Strijbos received his board certification in Medical Oncology in 2014.
In his daily practice, Dr. Strijbos focuses on the research and treatment of genitourinary malignancies, as well as sarcoma. He is currently active in several task forces and committees with regards to GU malignancies and is a principal investigator in several clinical trials in this field. He is also a member of the European Organisation for Research and Treatment of Cancer (EORTC) GU group.
Since early on in his carrier, Dr. Strijbos has played an active role within ESMO. In 2013, he joined the Young Oncologists Committee, where he was heavily involved in the YOC Burnout Survey and several other initiatives. Currently, he is active in the ESMO GU faculty, serves as an associate editor for the ESMO Open GU section, and is member of the ESMO Educational Publications Working Group.